Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Country / region: Israel Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20141
20161
20182
20212
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Active, not recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Hadassah Medical Organization2
Anchiano Therapeutics Israel Ltd.1
Bristol-Myers Squibb1
Compugen Ltd1
Famewave Ltd.1
Immune System Key Ltd1
Michael Har-Noy1
Regeneron Pharmaceuticals1
Sheba Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms13
Melanoma5
Carcinoma, Non-Small-Cell Lung4
Breast Neoplasms3
Triple Negative Breast Neoplasms3
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Endometrial Neoplasms2
Fallopian Tube Neoplasms2
Sarcoma2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.